Cargando…
The Efficacy and Safety of Intralesional Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis in Children under the Age of Two Years
Autores principales: | Hussein, Nawfal R, Naqid, Ibrahim A, Salih, Haval M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202348/ https://www.ncbi.nlm.nih.gov/pubmed/32395216 http://dx.doi.org/10.4084/MJHID.2020.027 |
Ejemplares similares
-
Evaluating the Efficacy of Combined Intralesional Sodium Stibogluconate Plus Topical Imiquimod on Healing and Risk of Scarring of Cutaneous Leishmaniasis: A Case-Control Study
por: Dhaher, Samer A, et al.
Publicado: (2022) -
Effectiveness of intralesional sodium stibogluconate for the treatment of localized cutaneous leishmaniasis at Boru Meda general hospital, Amhara, Ethiopia: Pragmatic trial
por: Tilahun Zewdu, Feleke, et al.
Publicado: (2022) -
LEISHMANIASIS OF THE LIP DIAGNOSED BY LYMPH NODE ASPIRATION AND TREATED WITH A COMBINATION OF ORAL KETACONAZOLE AND INTRALESIONAL SODIUM STIBOGLUCONATE
por: Vasudevan, Biju, et al.
Publicado: (2011) -
Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination
por: Silva, Hermali, et al.
Publicado: (2021) -
Monitoring Toxicity Associated with Parenteral Sodium Stibogluconate in the Day-Case Management of Returned Travellers with New World Cutaneous Leishmaniasi
por: Wise, Emily S., et al.
Publicado: (2012)